Vietnam Cell Therapy Market Size, Share, Trends and Forecast by Cell Therapy Type, Therapy Type, Therapeutic Area, End User and Region, 2026-2034

Vietnam Cell Therapy Market Overview:

The Vietnam cell therapy market size reached USD 71.83 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 232.66 Million by 2034, exhibiting a growth rate (CAGR) of 13.95% during 2026-2034. The market is driven by increasing government investments in biotechnology research, rising occurrence of chronic diseases, growing healthcare infrastructure development, and progressive regulatory frameworks supporting advanced therapeutic solutions. The growing emphasis on regenerative medicine approaches and expanded access to personalized treatments are further expanding the Vietnam cell therapy market share.

Vietnam Cell Therapy Market Trends:

Evolution of Regulatory Framework Creation

Vietnam's cell therapy regulatory environment is undergoing revolutionary shifts that are helping to introduce more friendly conditions for market expansion. The Vietnamese Ministry of Health has been adopting forward-thinking policies that simplify the approval process of cell therapies, with clinical trial approval times cut to 4-6 months, considerably shorter than that of regional peers. The government's recent issue of draft amendments to the Law on Donation, Recovery, and Transplantation of Human Tissues and Organs contains explicit provisions on stem cells, the first extensive regulatory system targeting the sector. This development in regulation gives researchers and biotechnology firms more distinct guidelines, lowering bureaucratic ambiguity and injecting domestic and foreign investment. The construction of Good Manufacturing Practice (GMP) compliant facilities and conformity with International Council for Harmonisation (ICH) standards ensures Vietnamese cell therapy products are globally recognized as meeting quality standards.

Increasing Healthcare Infrastructure Investment

Vietnam's massive investment in healthcare infrastructure is building a strong base for cell therapy market growth across the nation. In 2025, The government of Vietnam has enacted Decree 188/2025/ND-CP, which outlines the plan for establishing health insurance coverage for outpatient services at primary healthcare centers. The government stated that this policy represents progress in reducing the disparity in benefits for patients who obtain treatment from their registered facilities compared to those who seek care elsewhere. Large hospitals and academic medical institutions are setting up specialized cell therapy centers and GMP-capable manufacturing facilities, shortening treatment times and increasing patient accessibility. The convergence of advanced medical equipment and digital health technology is improving the accuracy and consistency of cell therapy applications in a range of therapeutic areas. Northern Vietnam, Central Vietnam, and Southern Vietnam regions are especially getting a boost from this infrastructure development, as regional patient populations are being served by specialized cell therapy centers. The upgraded healthcare infrastructure is facilitating Vietnam to carry out more sophisticated clinical trials and facilitate commercialization of cutting-edge therapeutic solutions.

Increasing Prevalence of Target Diseases

Growing prevalence of chronic and age-related diseases in Vietnam is driving the demand for innovative cell therapy treatments in various therapeutic indications. Cancer incidence is rising in the country, with malignancies contributing to the Vietnam cell therapy market growth. The increasing musculoskeletal disease burden, especially among Vietnam's aging population, is catalyzing the demand for regenerative medicine strategies that can treat joint degeneration and tissue damage better than current conventional treatment options. Autoimmune diseases and dermatological disorders are also driving market expansion as patients and doctors look for alternatives to traditional therapy that may provide limited long-term benefit. The Vietnamese health system has included new coverage for a range of innovative treatments, with the Ministry of Health introducing immunotherapies and sophisticated cell-based therapies to insurance company lists in recent years. Clinical uses have already proven to be effective in the treatment of diseases like knee osteoarthritis, chronic obstructive pulmonary disease, autism, and cerebral palsy, and provide a firm ground for wider therapeutic uses.

Strengthening Research and Development (R&D) Ecosystem

Vietnam's cell therapy R&D environment is witnessing rapid growth through strategic alliances, academic partnerships, and investments from the private sector that are driving innovation and clinical translation. Research institutions and universities are establishing partnerships with foreign biotechnology firms and academic institutions to augment their cell therapy research capacity and gain access to advanced technologies. The development of specialized stem cell laboratories and biobanks is giving the infrastructure required for large-scale cell production, storage, and characterization necessary for commercial uses. Policies from the government to support biotechnology research have created good conditions for both domestic and foreign enterprises to set up research operations in Vietnam, facilitating knowledge transfer and technological innovation. Clinical trials for cell therapy uses have grown extensively, with Vietnamese institutions engaging in global multicenter trials and independently undertaking research on locally applicable disease states. The establishment of local manufacturing capacity is decreasing reliance on foreign cell therapy products and generating skills in quality control, regulatory affairs, and commercial manufacturing. Academic medical centers are increasingly collaborating with private sector partners to translate laboratory discoveries into viable therapeutic products, creating a more integrated innovation ecosystem that supports sustainable market growth.

Vietnam Cell Therapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on cell therapy type, therapy type, therapeutic area, and end user.

Cell Therapy Type Insights:

• Stem Cell
  • Bone Marrow
  • Blood
  • Umbilical Cord-Derived
  • Adipose-Derived Stem Cell
  • Others
• Non-Stem Cell

A detailed breakup and analysis of the market based on the cell therapy type have also been provided in the report. This includes stem cell (bone marrow, blood, umbilical cord-derived, adipose-derived stem cell, and others) and non-stem cell.

Therapy Type Insights:

• Autologous
• Allogeneic

The report has provided a detailed breakup and analysis of the market by therapy type. This includes autologous and allogeneic.

Therapeutic Area Insights:

• Malignancies
• Musculoskeletal Disorders
• Autoimmune Disorders
• Dermatology
• Others

A detailed breakup and analysis of the market based on the therapeutic area have also been provided in the report. This includes malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and others.

End User Insights:

• Hospitals and Clinics
• Academic and Research Institutes

The report has provided a detailed breakup and analysis of the market by end user. This includes hospitals and clinics and academic and research institutes.

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Vietnam Cell Therapy Market News:

• August 2025: Celltrion is accelerating its ASEAN expansion by entering Vietnam, one of the fastest-growing “pharmerging” pharmaceutical markets, with a focus on autoimmune disease therapies and oncology drugs. Following the establishment of its Vietnamese subsidiary in 2024, Celltrion has secured sales approvals for two flagship biologics, Remsima (ingredient: infliximab) for autoimmune diseases and Herzuma (trastuzumab) for breast and gastric cancers. The company launched Remsima in June and Herzuma in August this year.
• January 2025: VinUniversity, Vinmec, and the PPD™ clinical research business of Thermo Fisher Scientific officially signed a MOU at Vinmec, marking the beginning of a transformative partnership in clinical research and cell therapy development. This collaboration sets the stage for groundbreaking advancements in healthcare and reinforces Vietnam’s position in the global clinical research community.

Vietnam Cell Therapy Market Report Coverage:

Key Questions Answered in This Report:

• How has the Vietnam cell therapy market performed so far and how will it perform in the coming years?
• What is the breakup of the Vietnam cell therapy market on the basis of cell therapy type?
• What is the breakup of the Vietnam cell therapy market on the basis of therapy type?
• What is the breakup of the Vietnam cell therapy market on the basis of therapeutic area?
• What is the breakup of the Vietnam cell therapy market on the basis of end user?
• What is the breakup of the Vietnam cell therapy market on the basis of region?
• What are the various stages in the value chain of the Vietnam cell therapy market?
• What are the key driving factors and challenges in the Vietnam cell therapy market?
• What is the structure of the Vietnam cell therapy market and who are the key players?
• What is the degree of competition in the Vietnam cell therapy market?

Key Benefits for Stakeholders:

• IMARC's industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Vietnam cell therapy market from 2020-2034.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Vietnam cell therapy market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Vietnam cell therapy industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.